Keybank National Association OH increased its position in Agilent Technologies Inc (NYSE:A) by 0.4% during the third quarter, HoldingsChannel.com reports. The firm owned 59,694 shares of the medical research company’s stock after acquiring an additional 229 shares during the quarter. Keybank National Association OH’s holdings in Agilent Technologies were worth $4,574,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the stock. Flagship Harbor Advisors LLC lifted its stake in Agilent Technologies by 139.0% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 203 shares during the period. Capital Investment Advisory Services LLC bought a new position in Agilent Technologies during the 2nd quarter valued at about $26,000. Liberty Wealth Management LLC bought a new position in Agilent Technologies during the 2nd quarter valued at about $29,000. WealthStone Inc. bought a new position in Agilent Technologies during the 2nd quarter valued at about $31,000. Finally, Coastal Capital Group Inc. bought a new position in Agilent Technologies during the 2nd quarter valued at about $32,000.
A has been the topic of several research analyst reports. Barclays lowered their target price on shares of Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 9th. Needham & Company LLC upped their target price on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research note on Monday, August 19th. UBS Group cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 target price on the stock. in a research note on Friday, October 18th. Robert W. Baird restated an “outperform” rating and set a $82.00 target price (up previously from $79.00) on shares of Agilent Technologies in a research note on Thursday, August 15th. Finally, Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price on the stock. in a research note on Tuesday, July 16th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $84.00.
In related news, CEO Michael R. Mcmullen sold 24,635 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $77.50, for a total value of $1,909,212.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Heidi Fields sold 4,000 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $70.96, for a total transaction of $283,840.00. The disclosure for this sale can be found here. Insiders have sold a total of 32,635 shares of company stock valued at $2,507,293 in the last ninety days.
Shares of NYSE A traded up $0.73 during midday trading on Friday, hitting $76.64. 1,157,853 shares of the company’s stock traded hands, compared to its average volume of 2,235,919. Agilent Technologies Inc has a 1 year low of $62.00 and a 1 year high of $82.27. The stock has a market capitalization of $23.38 billion, a price-to-earnings ratio of 27.47, a price-to-earnings-growth ratio of 1.88 and a beta of 1.42. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.72 and a current ratio of 2.13. The firm has a fifty day moving average of $75.70 and a 200 day moving average of $72.83.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.04. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.24 billion. During the same quarter in the prior year, the firm earned $0.67 EPS. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, equities analysts anticipate that Agilent Technologies Inc will post 3.08 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. The ex-dividend date was Monday, September 30th. Agilent Technologies’s payout ratio is currently 23.66%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Read More: What is the quiet period?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.